HomeStocksROSSARI

R

Rossari Biotech

ROSSARI Share Price

Chemicals
mtfMTF 3.53x

545.60

-17.70 (-3.14%)loss

as on 29 Jan 2026 at 15:52

1D
icon
10K
icon
535
icon
80% Buy
Overview
News
History
Fundamentals
Investment Returns
Technicals
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers
Bulb

Today Rossari Biotech opened at 570.00 while its previous close was at 563.30. In todays trading session ROSSARI reached a high of 570.00 and low of 541.00. The average traded price for today is 553.00. The 50 DMA stands at 577.40 and 200 DMA is at 643.32. Looking at intraday trend, the stock is in Downtrend.

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

ROSSARI Stock Performance

View In-Depth arrow

Markets Today

High

570.00

Low

541.00

Open at

570.00

Prev Close

563.30

Volumes

22,704

Avg Price

553.00

Lower Circuit

436.50

Upper Circuit

654.70

Last Traded Details

Quantity

1

Time

15:52:21

Price Movement

541.00
545.60
570.00
Loss 0.85%down side
up side4.28% profit

Historical Performance

3 M High

663.00

3 M Low

501.90

1 Yr High

766.00

1 Yr Low

501.90

3 Yr High

972.70

3 Yr Low

501.90

5 Yr High

1,619.00

5 Yr Low

501.90

1-Year Performance

501.90
545.60
766.00
loss0.85%down side
up side4.28% profit

ROSSARI Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By Refinitiv from 5 analysts

Buy

80%

Hold

20%

Sell

0%


ROSSARI News

View All News arrow



ROSSARI Share Price History

View Price History arrow

ROSSARI Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

3,022

PE Ratio

22.60

PB Ratio

2.49

Dividend Yield

0.09%

ROE

11.50%

ROCE

14.93%

Book Value (₹)

225.97

Face Value (₹)

2.00


Share Holding Pattern

Held ByDec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters
68.19%68.18%68.17%68.17%68.16%
Domestic Institutional Investors (DII)
17.47%17.59%17.84%18.18%18.26%
Foreign Institutional Investors (FII)
3.74%3.98%3.48%2.69%2.33%
Public Investors
9.51%9.20%9.44%9.47%9.89%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


ROSSARI Return Calculator

You have invested

Investment Period

Investment of ₹1,00,000 for 5 years would have become

0

Loss

-1,00,000 (-38.16%)


ROSSARI Investment Returns

View In-Depth arrow

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


ROSSARI Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA538.05Bullish
10-SMA534.17Bullish
20-SMA553.21Bullish
50-SMA577.40Bearish
100-SMA610.00Bearish
200-SMA643.32Bearish

Technical Indicators

IndicatorValueAction
RSI(14)53.26Neutral
ATR(14)21.46Volatile
STOCH(9,6)45.88Neutral
STOCH RSI(14)92.78Overbought
MACD(12,26)2.27Bullish
ADX(14)31.54Strong Trend

Summary of Technical Indicators for ROSSARI


Margin on ROSSARI

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).


ROSSARI Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
514582545588583

ROSSARI Financials

View By:

Income Statement

In Crores

Quarterly StatementDec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue514582545588583
Expenses448510476514513
Operating Profit6570687269
Operating Profit Margin %13%12%12%12%12%
Other Income12221
EBITDA6671707470
Interest56668
Depreciation1818181820
Profit Before Tax4248465043
Tax %25%28%27%26%23%
Net Profit3234343733
EPS66676

Balance Sheet

In Crores

Yearly Balance SheetMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Share Capital1011111111
Reserve & Surplus3987949041,0371,174
Minority Interest00000
Non Current Liabilities2157104100174
Current Liabilities150295349425537
Total Liabilities5611,2571,3681,5721,896
Fixed Assets181607585578598
Capital Work in Progress011647140
Investments036516384
Other Assets3806127158851,074
Total Assets5611,2571,3681,5721,896

Cash Flow

In Crores

Yearly Cash FlowMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Activities482915243137
Investing Activities-37-299-181-104-183
Financing Activities-25292611665
Net Cash Flow-142232-4419

Corporate Actions

DateCorporate ActionInformation
17th Jan 2026, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 25-26 Results
info
15th Oct 2025, Wednesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 25-26 Results
info
19th Jul 2025, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 25-26 Results
info
20th Jun 2025, Friday
DIVIDENDDividend
Final Dividend of ₹0.5/share
25th Apr 2025, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 25-26 Results
info

The above dates are ex-dates.

View All Stock Events arrow

ROSSARI Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-251,437
19.01% profit
115
15.15% profit
FY 2023-241,210
23.35% profit
100
39.58% profit
FY 2022-23979
-9.1% Loss
71
-10.17% Loss

Top Mutual Funds Invested in ROSSARI



Top Gainers Today

View All Gainers arrow

Top Losers Today

View All Losers arrow

NSE Indices Today

All NSE Indices arrow

BSE Indices Today

All BSE Indices arrow

Open IPOs

View All arrow


What's New In The Market

FAQs on ROSSARI

Rossari Biotech share price as of today is ₹ 545.60 as on 29 Jan 2026 at 15:52.
The 52W high of Rossari Biotech is ₹ 766.00 and 52W low is ₹ 501.90 as of 29 Jan 2026 at 15:52.
The past returns of Rossari Biotech share are -
  • Past 1 year: -22.27%
  • Past 3 years: -22.20%
  • Past 5 years: -38.16%
The PE and PB ratio of Rossari Biotech stands at 22.60 and 2.49 respectively as on 29 Jan 2026 at 15:52.
The EPS of Rossari Biotech is 5.92 for the quarter ended Dec 2025 and 24.66 for the financial year 2024-25.
The shareholding pattern of Rossari Biotech is as follows:
  • DIIs - 18.26%
  • FII - 2.33%
  • Promoters - 68.16%
  • Public Investors 9.89%
  • Goverenment - 0.00%
Yes, you can buy shares of Rossari Biotech online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Rossari Biotech stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Rossari Biotech share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Rossari Biotech.
You can easily buy the shares of Rossari Biotech even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in ROSSARI
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors